Sarin: Health effects, metabolism, and methods of analysis

Food and Chemical Toxicology

Volumn 40, Issue 10, 2002, Pages 1327-1333

  Abu Qare, A W ^a   Abou Donia, M B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gulf War; Nerve agents; Organophosphates; Sarin

Indexed keywords

CHOLINESTERASE INHIBITOR; PYRIDOSTIGMINE; SARIN; TOXIC SUBSTANCE;

ACUTE TOXICITY; AIRWAY OBSTRUCTION; ANALYTIC METHOD; ANOXIA; ASTHENIA; BEHAVIOR DISORDER; BREATHING MUSCLE; CENTRAL NERVOUS SYSTEM; CHEMICAL WARFARE; CONVULSION; DEATH; ENDOCRINE SYSTEM; ENZYME SPECIFICITY; FATIGUE; FROZEN SHOULDER; GENETIC TRANSCRIPTION; HUMAN; HYPOTHERMIA; JAPAN; LONG TERM EXPOSURE; METABOLISM; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RESPIRATORY FAILURE; REVIEW; SEIZURE; SOLDIER; SYMPTOM; TREMOR; VISUAL IMPAIRMENT; WAR;

EID: 0036775127     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(02)00079-0     Document Type: Short Survey

References (75)

1. Abou-Donia M.B. Organophosphorous pesticides. Chang L.W., Dyer R.S. Handbook of Neurotoxicology. 1994;419-473 Marcel Dekker, New York.
2. Abou-Donia M.B. Involvement of cytoskeletal proteins in the mechanism of organophosphorus ester-induced delayed neurotoxicity. Clinical and Experimental Pharmacology and Physiology. 22:1995;358-359.
3. Abou-Donia M.B. Long-term effects of subchronic exposure to sarin, alone and with stress or other chemicals. Govt Reports Announcement and Index (GRA &I). 2:1999.
4. Abou-Donia M.B., Lapadula D.M. Mechanisms of organophosphorous ester-induced delayed neurotoxicity: type I and type II. Annual Review of Pharmcology and Toxicology. 30:1990;405-440.
5. Abou-Donia M.B., Lapadula D.M., Campbell G., Abdo K.M. The joint neurotoxic action of inhaled methyl butyl ketone vapor and dermally applied O-ethyl-O-4-nitrophenyl phenylphosphonothionate in hens: potentiating effects. Toxicology and Applied Pharmacology. 79:1985;69-82.
6. Abu-Qare A.W., Abou-Donia M.B. Simultaneous analysis of sarin, pyridostigmine bromide and their metabolites in rat urine and plasma by HPLC. Chromatographia. 53:2001;251-255.
7. Abu-Qare, A.W., Abou-Donia, M.B., 2001a. Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2′-deoxyguanosine, biomarkers of oxidative stress. Toxicology Letters 123, 52-58.
8. Bakshi K.S., Pang S.N.J., Snyder R. Evaluation of the army's interim reference dose for GB. Journal of Toxicology and Environmental Health Part A. 59:2000;313-321.
9. Bakshi K.S., Pang S.N.J., Snyder R. Appendix B: health risk assessment for the nerve agent GB. Journal of Toxicology and Environmental Health Part A. 59:2000;387-415.
10. Black R.M., Harrison J.M. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Archives of Toxicology. 73:1998;123-126.
11. Black R.M., Read R.W. Analysis of degradation products of organophosphorous chemical warfare agents and related compounds by liquid chromatography-mass spectrometry using electrospray and atmospheric pressure chemical ionization. Journal of Chromatography A. 759:1998;79-92.
12. Brown M.A., Brix K.A. Review of health consequences from high-, intermediate- and low level exposure to organophosphorous nerve agents. Journal of Applied Toxicology. 18:1998;393-408.
13. Carrington C.D., Abou-Donia M.B. The correlation between the recovery rate of neurotoxic esterase activity and sensitivity to organophosphorus-induced delayed neurotoxicity. Toxicology and Applied Pharmacology. 15:1984;350-357.
14. Chebabo S.R., Santos M.D., Abuquerque E.X. The organophosphate sarin, at low concentrations, inhibit the evoked release of GABA in rat hippocampal slices. Neurotoxicology. 20:1999;871-882.
15. Crowell J.A., Parker R.M., Bucci T.J., Dacre J.C. Neuropathy target esterase in hens after sarin and soman. Journal of Biochemical Toxicology. 4:1989;15-20.
16. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman, and sarin. Nature Genetics. 14:1996;334-336.
17. Davis S.L., Tanaka D., Aulerich R.J., Bursian S.J. Organophosphorus-induced neurotoxicity in the absence of neuropathy target esterase inhibition: the effects of triphenyl phosphine in the European ferret. Toxicological Sciences. 49:1999;78-85.
18. D'Agostino P.A., Hancock J.R., Provost L.R. Packed capillary liquid chromatography-electrospray mass spectrometry analysis of organophosphorus chemical agents. Journal of Chromatography A. 840:1999;289-294.
19. Fulco C.E., Liverman C.T., Sox H.C. Gulf War and Health. Vol. 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines. 2000;National Academy of Sciences Press, Washington, DC.
20. Gordon J., Inns R., Johnson M., Leadbeater L., Maidment M., Upshall D., Cooper G., Rickard R. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Archives of Toxicology. 52:1983;71-82.
21. Gupta R.C., Patterson G.T., Dettabarn W.G. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat. Fundamental and Applied Toxicology. 16:1991;449-458.
22. Hammond P.S., Forster J.S., Lieske C.N., Durst H.D. Hydrolysis of toxic organophosphorus compounds by o-iodobenzoic acid and its derivatives. Journal of the American Chemical Society. 111:1989;7866-7869.
23. Henderson, R.F., 2000. Long-term Effects of Subclinical Exposures to Sarin (Report by US Army Medical Research and Material Command, DAMD 20010105 020).
24. Himuro K., Murayama S., Nishiyama K., Shinoe T., Iwase H., Nagao M., Takatori T., Kanazawa I. Distal sensory axonopathy after sarin intoxication. Neurology. 51:1998;1195-1197.
25. Hui D.M., Minami M. Monitoring of fluorine in urine samples of patients involved in the Tokyo sarin disaster, in connection with the detection of other decomposition products of sarin and the by-products generated during sarin synthesis. Clinica Chimica Acta. 302:2000;171-188.
26. Husain K., Vijayaraghavan R., Pant S.C., Raza S.K., Pandy K.S. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. Journal of Applied Toxicology. 13:1993;143-145.
27. Jones K.H., Dechkovskaia A.M., Herrick E.A., Abdel-Rahman A.A., Khan W.A., Abou-Donia M.B. Subchronic effects following a single sarin exposure on blood-brain and blood-testes barrier permeability, acetylcholinesterase, and acetylcholine receptors in the central nervous system of rat: a dose-response study. Journal of Toxicology and Environmental Health Part A. 61:2000;695-707.
28. Kassa J., Krocova Z., Vachek J. The long-term changes in liver DNA and total protein content following low level sarin exposure in rats. Acta Medica. 43:2000;19-22.
29. Kassa J., Krocova Z., Vachek J. Long term inhalation of immune functions following low level exposure to sarin in rats. Acta Medica. 43:2000;91-94.
30. Kassa J., Koupilova M., Herink J., Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica. 44:2001;21-27.
31. Kassa J., Pecka M., Tichy M., Bajgar J., Koupilova M., Hernik J., Krocova Z. Toxic effects of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacology and Toxicology. 88:2001;209-212.
32. Katagi M., Tatsuno M., Nishikawa M., Tsuchihashi H. Onl-line solid-phase extraction liquid chromatography-continue flow frit fast atom bombardment mass spectrometric and tandem mass spectrometric determination of hydrolysis products of nerve agents alkyl methylphosphonic acids by p-bromophenacyl derivatization. Journal of Chromatography A. 833:1999;169-179.
33. Khan G.J., Bauman R.A., Feaster S.R., Anderson S.M., Saviolakis G.A., Garcia G.E. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alteration performance in rats. Pharmacology, Biochemistry and Behaviour. 70:2001;209-218.
34. Khan W.A., Dechkovskaia A.M., Herrick E.A., Jones K.H., Abou-Donia M.B. Acute sarin exposure causes differential regulation of choline acetyltransferase, acetylcholinesterase, and acetylcholine receptors in the central nervous system of the rat. Toxicologic Science. 57:2000;112-120.
35. LaBorde J.B., Bates H.K., Dacre J.C., Young J.F. Developmental toxicity of sarin in rats and rabbits. Journal of Toxicology and Environmental Health. 47:1996;249-265.
36. Lee W.E., Thompson H.G., Hall J.G., Bader D.E. Rapid detection and identification of biological and chemical agents by immunoassay, gene probe assay and enzyme inhibition using a silicon-based biosensor. Biosensors and Bioelectronics. 14:2000;795-804.
37. Li Q., Minami M., Clement J.G., Boulet C.A. Elevated frequency of sister chromatid exchanges in lymphocytes of victims of the Tokyo sarin disaster and in experiments exposed lymphocytes to by-products of sarin synthesis. Toxicology Letters. 98:1998;95-103.
38. Li Q., Hirata Y., Piao S., Minami M. The by-product generated during sarin synthesis in the Tokyo sarin disaster induced inhibition of natural killer and cytotoxic lymphocyte activity. Toxicology. 146:2000;209-220.
39. 3H]sarin and its metabolites in mice. Toxicology and Applied Pharmacology. 38:1986;412-419.
40. Lotti M. Organophosphorous compounds. Spencer P., Schaubung H., Ludolph A. Experimental and Clinical Neurotoxicology. Second ed. 2000;897-925 Oxford University Press, New York.
41. Matsuda Y., Nagao M; Takatori, T; Nijima H; Nakajima, M; Iwase H; Kobayashi, M; Iwadate K. Detection of sarin hydrolysis products in formalin-fixed brain tissues of victims of the Tokoyo subway terrorist attack. Toxicology and Applied Pharmacology. 150:1998;310-320.
42. McCauley L.A., Rischitelli G., Lambert W.E., Lasarew M., Sticker D.L., Spencer P.S. Symptoms of Gulf War veterans possibly exposed to organophosphate chemical nerve agents at Khamisiyah, Iraq. International Journal of Occupational and Environmental Health. 7:2001;79-89.
43. Miki A., Katagi M., Tsuchihashi H., Yamashita M. Determination of alkylmethylphosphonic acids, the main metabolites of organophosphorus nerve agents, in biofluids by gas chromatography-mass spectrometry and liquid-liquid-solid-phase-transfer-catalyzed pentafluorobenzylation. Journal of Analytical Toxicology. 23:1999;86-93.
44. Minami M., Hui D.M., Katsumata M., Inagaki H., Boulet C.A. Method for the analysis of the methylphosphonic acid metabolites of sarin and its ethanol-substituted analogue in urine as applied to victims of the Tokyo sarin disaster. Journal of Chromatography B. 695:1997;237-244.
45. Munro N.B., Talmage S.S., Griffin G.D., Waters L.C., Watson A.P., King J.F., Hauschild V. The sources, fate, and toxicity of chemical warfare agent degradation products. Environmental Health Perspectives. 107:1999;933-947.
46. Murata K., Araki S., Yokoyama K., Okumura T., Ishimatsu S., Takasu N., White R.F. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic system 6 months after the Tokyo subway attack. Journal of Neurology. 244:1997;601-606.
47. Nakajima T., Ohta S., Morita H., Midorikawa Y., Mimura S., Yanagisawa N. Epidemiological study of sarin poisoning in Matsumoto City, Japan. Journal of Epidemiology. 8:1998;3-41.
48. Nakajima T., Sasaki K., Ozawa H., Sekijima Y., Morita H., Fukushima Y., Yanagiswa N. Urinary metabolites of sarin in a patient of the Matsumoto sarin incident. Archives of Toxicology. 72:1998;601-603.
49. Nakajima T., Ohta S., Fukushima Y., Yanagisawa N. Sequele of sarin toxicity at one and three years after exposure in Matsumoto, Japan. Journal of Epidemiology. 9:1999;337-343.
50. Nassar A.E., Lucas S.V., Myler C.A., Jones W.R., Campisano M., Hoffland L.D. Quantitative analysis of chemical warfare agent degradation products in reaction masses using capillary electrophoresis. Analytical Chemistry. 70:1998;3598-3604.
51. Nieminen S.A., Lecklin A., Heikkinen O., Ylitalo P. Acute behavioral effects of the organophosphosates sarin and soman in rats. Pharmacology and Toxicology. 67:1990;36-40.
52. Niijima H., Nagao M., Nakajima M., Takatori T., Matsuda Y., Iwase H., Kobayashi M. Sarin-like and soman-like organophosphorous agents activate PLCgamma in rat brains. Toxicology and Applied Pharmacology. 156:1999;64-69.
53. Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Minami M., Omae K. Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environmental Health Perspectives. 109:2001;1169-1173.
54. Noort D., Hulst A.G., Platenburg D.G., Polhuijs M., Benschop H.P. Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: estimation of internal dosage. Archives of Toxicology. 72:1998;671-675.
55. Oehrle S.A., Bossle P.C. Analysis of nerve agent degradation products using capillary ion electrophoresis. Journal ofChromatography B. 692:1995;247-252.
56. Pearce P.C., Crofts H.S., Muggleton N.G., Ridout D., Scott E.A. The effects of acutely administered low dose sarin on cognitive behavior and the electroencephalogram in the common marmoset. Journal of Psychopharmacology. 13:1999;128-135.
57. 11C]-sarin. Journal of Radiolabelled Compounds and Radiopharmaceuticals. 18:1990;645-651.
58. Ray D.E. Chronic effects of low level exposure to anticholinesterases - a mechanistic review. Toxicology Letters. 28:1998;527-533.
59. Rickett D.L., Glenn J.F., Beers E.T. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology. 7:1986;225-236.
60. Satoh T., Hosokawa M. Organophosphates and their impact on the global environment. Neurotoxicology. 21:2000;223-227.
61. Shih T.M., McDonough J.H. Organophosphorous nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacology, Biochemistry and Behaviour. 64:1999;147-153.
62. Shih L.S., McMonagle J.D., Doizine W.T., Gresham C.V. Metabolite pharmacokinetics of soman, sarin, and GF in rat and biological monitoring of exposure to toxic organophosphorous agents. Journal of Applied Toxicology. 14:1994;195-199.
63. Shih L.M., Smith J.R., McMonagle J.D., Dolzine W.T., Gresham C.V. Detection of metabolites of toxic alkylmethylphosphonates in biological samples. Biology and Mass Spectrometry. 20:1991;717-723.
64. Sidell F.R., Borak J. Chemical warfare agents: II. Nerve agents. Annals of Emergency Medicine. 21:1992;865-871.
65. Somani S.M. Chemical Warfare Agents. 1992;Academic Press, New York.
66. Spruit H.E., Langenberg J.P., Trap H.C., Van der Wiel H.J., Helmich R.B., Van Helden H.P., Benschop H.P. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicology and Applied Pharmacology. 169:2000;249-254.
67. Suzuki J., Kohno T., Tsukagosi M., Furuhata T., Yamazaki K. Eighteen cases exposed to sarin in Matsumoto, Japan. Internal Medicine. 36:1997;466-470.
68. Suzuki O., Seno H., Watnanble-Suzuki K., Ishii A. Situations of poisoning and analytical toxicology in Japan. Forensic Science International. 113:2000;331-338.
69. Vermillion W.D., Crenshaw M.D. In-line respeciation: an ion-exchange ion chromatographic method applied to the separation of degradation products of chemical warfare nerve agents in soil. Journal of Chromatography A. 770:1997;253-260.
70. Weiner M.L., Jortner B.S. Organophosphate-induced delayed neurotoxicity of triarylphosphates. Neurotoxicology. 20:1999;653-673.
71. Wilson B.W., Henderson J.D., Spencer P.S. Clinical effects of low-level exposures to chemical warfare agents in mice and chicken. Drug and Chemical Toxicology. 21(Suppl):183-190.
72. Xie Y., Popov B.N. Catalyzed hydrolysis of nerve gases by metal chelate compounds and potentiometric detection of the byproducts. Analytical Chemistry. 72:2000;2075-2079.
73. Yokoyama K., Araki S., Murata K., Nishikitani M., Okumura T., Ishimatsu Takasu N. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. Journal de Physiologie, Paris. 92:1998;317-323.
74. Yokoyama K., Araki S., Murata K., Nishikitani M., Okumura T., Ishimatsu Takasu N. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Archives of Environmental Health. 53:1998;249-256.
75. Young J.F., Gough B.J., Suber R.L., Gaylor D.W. Correlation of blood cholinesterase levels with toxicity of sarin in rats. Journal of Toxicology and Environmental Health Part A. 62:2001;161-174.